Pierre Fabre, partner of the Toulouse Onco Week

January 29, 2016

Pierre Fabre laboratories, 2nd largest French independent pharmaceutical group, announce their participation to the 1st edition of the Toulouse Onco Week which will take place from February 3rd to 5th at the Pierre Baudis Congress Center in Toulouse under the High Patronage of Mr. François Hollande, President of the Republic of France. 

The Toulouse Onco Week is organized by the Cancer Research Center of Toulouse (CRCT) in partnership with Cancer-Bio-Health Competitiveness Cluster, the French Institute of Health and Medical Research (Inserm), the Toulouse Cancer Santé foundation, Toulouse Métropole and the agency So Toulouse. In addition to their institutional support, Pierre Fabre laboratories will share their research results in oncology via the presentation of 10 abstracts. Pierre Fabre R&D oncology and onco-dermatology team will welcome attendees at the company’s booth and Laurent Audoly, Head of R&D for Pierre Fabre Pharmaceutical Division, will present Pierre Fabre laboratories on February, 3rd.

The group’s participation and support to this event demonstrate its strong commitment to the Toulouse region and its Cancer Research Center’s development, the Oncopole, as a global center of excellence in oncology. Pierre Fabre, which R&D Center is located on the Oncopole Campus and gathers over 500 employees, is one of the Oncopole’s historic ambassador and major private stakeholder. Unique in Europe, the Oncopole is a campus gathering on the same site public and private actors in research, training, patient, business, technology platforms, clinical trials to fight against cancer.

The Toulouse Onco Week is a new opportunity for Pierre Fabre laboratories to present their expertise and research projects in oncology and to share experience with the numerous scientists and international innovators that will attend the event in Toulouse. It is therefore an event that falls within the framework of our Open Innovation strategy and that highlights our unfailing support to the Toulouse region which is worldwide known for its oncology research, comments Bertrand Parmentier, general manager of Pierre Fabre laboratories.